Evidence map›Paper›PMID 28007666›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2017

Real Time Immunophenotyping of Leukocyte Subsets Early after Double Cord Blood Transplantation Predicts Graft Function.

Jianqiang Li, Ian Nicoud, Joseph Blake, David Oliver, Emily Cox, Shelly Heimfeld, Filippo Milano, Suzan Imren, Colleen Delaney

Abstract read
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jianqiang LiClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Ian NicoudClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Joseph BlakeClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
David OliverClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Emily CoxClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Shelly HeimfeldClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Filippo MilanoClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
Suzan ImrenClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Colleen DelaneyClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington. Electronic address: cdelaney@fredhutch.org.

Funding

Notch-Mediated Expansion of Cord Blood Progenitors for Stem Cell TransplantP50HL110787 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DELANEY, COLLEEN · 2012 to 2017
$12.4M
Stem Cell and Transplantation BiologyU54DK106829 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DEREK L STIREWALT · 2015 to 2026
$9.1M
NHLBI NIH HHS P50 HL110787NIDDK NIH HHS U54 DK106829
6 · The paper itself

Abstract

Cord blood transplantation (CBT) recipients are at increased risk for delayed engraftment and primary graft failure, complications that are often indistinguishable early post-transplantation. Current assays fail to accurately identify recipients with slow hematopoietic recovery and distinguish them from those with pending graft failure. To address this, we prospectively examined the kinetics of immune cell subset recovery in the peripheral blood of 39 patients on days +7 and +14 after double-unit CBT (dCBT) by multiparametric flow cytometry analysis, which we term real-time immunophenotyping (RTIP). RTIP analysis at day +14 revealed distinctive patterns of reconstitution and, importantly, identified patients with slow hematopoietic recovery who went on to engraft. Strikingly, higher absolute numbers of circulating monocytes and natural killer cells at day +14 were predictive of engraftment, but only the absolute number of circulating monocytes was significantly correlated with time to engraftment. This is the first evidence that RTIP on patient peripheral blood mononuclear cells early after dCBT is technically feasible and can be used as a "signature" for predicting the kinetics of hematopoietic recovery. Furthermore, RTIP is a time- and cost-efficient methodology that has the potential to become a clinically feasible diagnostic tool to guide therapeutic interventions in high-risk patients; therefore, its utility should be evaluated in a large cohort of patients.

Indexed as

Graft SurvivalImmunophenotypingAdolescentAdultChildCord Blood Stem Cell TransplantationDelayed Graft FunctionFemaleFlow CytometryHumansKineticsLeukocytesLeukocytes, MononuclearMaleMiddle AgedPrognosisCord blood transplantDelayed engraftmentEngraftment kineticsPrimary graft failureReal-time immunophenotyping

Identifiers

PMID28007666
PMCPMC5348257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.